FDA updates labeling for BRIXADI FDA Approval Dec. 31, 2025, 13:45 UTC Labeling changes approved for BRAEBURN. Active ingredient: BUPRENORPHINE. Decision date: 12/22/2025 Full text
There are no comments here yet...